No
Noile-Immune
Tokyo JPFounded 201540 employees
Private CapbiotechPrivateOncology
Platform: PRIME CAR-T
Market Cap
N/A
All Drugs
4
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zenovorutinib | NOI-4026 | Phase 2 | 1 | GPRC5D | ObesityMigraine | ||
| NOI-8348 | NOI-8348 | Preclinical | 1 | Menin | FLFabry | ||
| Mirinesiran | NOI-5293 | Phase 2 | 2 | FcRn | CeliacFTD | ||
| NOI-4498 | NOI-4498 | Phase 1 | 1 | Cl18.2 | SLEPsA |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)